Fundz

Red Shift Bio Analytics, Inc. reported raising $6.4 Million in an initial SEC Form D filing, from an offering of $6.44 Million

PRIVATEDec 23, 2020$6.4M of $6.4M raised

Amount Raised

$6.4 Million

$6.4 Million sold, per SEC Form D (first sale Dec 23, 2020)

Round Type

Venture

BoxboroughInformation TechnologyBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as RedShift BioAnalytics that raised within 45 days of this round, from Fundz verified event records.

  • ISOThrive raised $5.2M on February 5, 2021.
  • Kate Therapeutics raised $16M on February 5, 2021.
  • Anpath Group, Inc. raised $2.5M (Seed) on February 5, 2021.
  • Exacis Biotherapeutics Inc. raised $50K (Seed) on February 4, 2021.
  • NeuraMedica raised $1.1M (Seed) on February 4, 2021.
  • Circle8 Group Inc raised $350K (Seed) on February 3, 2021.

Who to call at RedShift BioAnalytics, and when

A new round usually means RedShift BioAnalytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RedShift BioAnalytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RedShift BioAnalytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RedShift BioAnalytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RedShift BioAnalytics

Location

Boxborough, Massachusetts, United States

About

RedShiftBio is redefining the analysis of protein, mabs, peptides, RNA, and LNP structure and concentration. RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high-powered quantum cascade lasers that provide ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. This combination of technologies is available to researchers in our fully-automated Aurora and Apollo systems and is backed by a global network of sales, applications, service, and support teams to address all market needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RedShift BioAnalytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts23 people are listed at RedShift BioAnalytics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for RedShift BioAnalytics's next move

See what Strategic adds

RedShift BioAnalytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.